Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression

Journal of NeuroVirology

Volumn 17, Issue 2, 2011, Pages 176-183

  Cysique, Lucette A ^a,b   Brew, Bruce J ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Antiretroviral treatment; HIV RNA; HIV associated dementia; HIV AIDS; Neurological complications; Neuropsychological functions

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEUROCOGNITIVE IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TREATMENT DURATION; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUSTRALIA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COGNITION DISORDERS; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RNA, VIRAL; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 79959941693     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0021-x     Document Type: Article

References (50)

1. Basso MR, Bornstein RA (2000) Estimated pre-morbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol 22:208-218 (Pubitemid 30331189)
2. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63:213-221 (Pubitemid 351355300)
3. Brew BJ (2004) Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18:S75-S78 (Pubitemid 38365909)
4. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2008) Neurodegeneration and Ageing in the HAART Era. J Neuroimmune Pharmacol 6:6
5. Byrd D, Morgello S, Franklin D, Heaton RK, Grant I (2009) Substance use and HIV infection: neurocognitive effect, the CHARTER Cohort. In: 16th Conference on Retroviruses and Opportunistic Infections. http://www. retroconference.org/2009/Abstracts/34478.htm: Montreal, Canada, pp 478
6. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319 (Pubitemid 39277061)
7. Carter SL, Rourke SB, Murji S, Shore D, Rourke BP (2003) Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology 17:410-419 (Pubitemid 37013152)
8. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66:253-258
9. Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW (2007) Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol 85:261-300
10. Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller EN (2007) Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 69:2213-2220 (Pubitemid 350294676)
11. Cunningham P, Smith D, Satchell C, Cooper DA, Brew B (2000) Evidence for independant development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14:1949-1954
12. Cysique L, Maruff P, Brew B (2004a) Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 61:1699-1704 (Pubitemid 39463428)
13. Cysique L, Maruff P, Brew B (2004b) Prevalence and pattern of neuropsychological impairment in HIV/AIDS-infection across pre and post-highly active antiretroviral therapy eras: a combined study of 2 cohorts. J Neurovirol 10:350-357 (Pubitemid 40109622)
14. Cysique L, Vaida F, Letendre S, Gibson S, Woods S, Cherner M, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV+individuals initiating antiretroviral therapy. Neurology 27:27
15. Cysique LA, Deutsch R, Atkinson JH, Young C, Marcotte TD, Dawson L, Grant I, Heaton RK (2007) Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc 13:1-11 (Pubitemid 46487370)
16. Cysique LA, Maruff P, Brew BJ (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66:1447-1450 (Pubitemid 43739663)
17. Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ (2011) HIV and Age Do Not Substantially Interact in HIV-Associated Neurocognitive Impairment. J Neuropsychiatry Clin Neurosci 23:83-89
18. Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM (2001) Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 344:472-480 (Pubitemid 32164898)
19. Dore GJ, McDonald A, Li Y, Kaldo JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17:1539-1545 (Pubitemid 36900555)
20. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson BS, Abramson I, Grant I, McCutchan JA (2000) Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54:927-936 (Pubitemid 30111354)
21. Goggin KJ, Zisook S, Heaton RK, Atkinson HJ, Marshall S, McCuthchan JA, Chandler JL, Grant I, group at H (1997) Neuropsychological performance of HIV-1 infected men with major depression. J Int Neuropsychol Soc 3:457-464
22. Gulick R, Staszewski S (2002) New drugs for HIV therapy. AIDS 16:S135-S144 (Pubitemid 36278938)
23. Heaton RK, Franklin1 D, Clifford D, Woods S, Rivera Mindt M, Vigil O, Taylor M, Marcotte T, Atkinson H, Grant I (2009) HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: The CHARTER study. In: 16th Conference on retroviruses and opportunistic infections. http://www.retroconference.org/2009/Abstracts/35664.htm: Montreal, Canada, pp 154
24. Heaton RK, Miller SW, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded halstead-reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults scoring program. Psychological Assessment Resources, Odessa
25. Hilsabeck RC, Castellon SA, Hinkin CH (2005) Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis 41(Suppl 1):S38-S44 (Pubitemid 40863723)
26. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65-70
27. Letendre S, McClernon D, Ellis R, Muñoz-Moreno J, Way L, Franklin D, Heaton R, Grant I, CHARTER Group (2009) Persistent HIV in the Central Nervous System during Treatment is Associated with Worse ART Penetration and Cognitive Impairment. In: 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada, pp 484b
28. Letendre S, McCutchan J, Childers M, Woods S, Lazzaretto D, Heaton R, Grant I, Ellis R, Group. H (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56:416-423 (Pubitemid 39166561)
29. Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation, Sydney
30. McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL (2007) HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS 21:1109-1117 (Pubitemid 46763281)
31. Nelson H, Willison J (1982) National Adult Reading Test (NART). Test manual, 2nd edn. NFER-NELSON, Windsor
32. Norman MA, Evans JD, Miller SW, Heaton RK (2000) Demographically corrected norms for the California Verbal Learning Test. J Clin Exp Neuropsychol 22:80-94 (Pubitemid 30114645)
33. Perneger TV (1998) What's wrong with Bonferroni adjustments. BMJ 316:1236-1238 (Pubitemid 28171344)
34. Riedel DJ, Pardo CA, McArthur J, Nath A (2006) Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol 2:557-565 (Pubitemid 44445811)
35. Roberston K, Roberston TW, Ford S, Watson D, Fiscus S, Harp AG, Hall D (2004) Highly Active Antiretroviral Therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36:562-566 (Pubitemid 38544504)
36. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915-1921 (Pubitemid 47329768)
37. Rumbaugh JA, Nath A (2006) Developments in HIV neuropathogenesis. Curr Pharm Des 12:1023-1044
38. Sacktor N, McDermott M, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo P, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142 (Pubitemid 34520894)
39. Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I (2005) Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol 11:356-364 (Pubitemid 41614515)
40. Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K (2004) Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63:2084-2090 (Pubitemid 39636256)
41. Stern RA, Silva SG, Chaisson N, Evans DL (1996) Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 53:148-153 (Pubitemid 26055261)
42. Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448-460 (Pubitemid 34296102)
43. Stern Y, McDermott M, Albert S, Palumbo P, Selnes OA, McArthur JC, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder K, Disorders ftDcotToH-DaRC (2001) Factors associated with incident human immonodefiency virus-dementia. Arch Neurol 58:473-479 (Pubitemid 32217465)
44. Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, Oxford
45. Trillo-Pazos G, Kandanearatchi A, Eyeson J, King D, Vyakarnam A, Everall IP (2004) Infection of stationary human brain aggregates with HIV-1 SF162 and IIIB results in transient neuronal damage and neurotoxicity. Neuropathol Appl Neurobiol 30:136-147 (Pubitemid 38496704)
46. Uchiyama CL, D'Elia LF, Dellinger AM, Selnes OA, et al. (1994) Longitudinal comparison of alternate versions of the symbol digit modalities test: issues of form comparability and moderating demographic variables. Clin Neuropsychol 8:209-218 (Pubitemid 24220535)
47. Valcour V, Paul R (2006) HIV infection and dementia in older adults. Clin Infect Dis 42:1449-1454
48. Valcour V, Shikuma C, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004) Higher frequency of dementia in older HIV-1 individuals. The Hawaii aging with HIV-1 cohort. Neurology 63:822-827 (Pubitemid 39297641)
49. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75:864-873
50. Yeni P, Hammer S, Carpenter C, Cooper D, Fischl M, Gatell J, Gazzard B, Hirsch M, Jacobsen D, Katzenstein D, Montaner J, Richman D, Saag M, Schechter M, Schooley R, Thompson M, Vella S, Volberding P (2002) Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 288:222-235 (Pubitemid 34755283)